World Spinal Fusion Market Examined & Forecast in In-demand Renub Research Report Published at MarketPublishers.com

11 Jan 2016 • by Natalie Aster

LONDON – Spinal fusion is a multi-billion dollar market with great potential for future. As of 2014, the global market value went beyond USD 20 billion. The USA, Germany and China are the world’s 3 leading spinal fusion markets. In 2014, the volume of spinal fusion procedures has crossed the 1 million mark. The rate of spinal fusion surgeries in India was higher in comparison with France in 2014. The global spinal fusion market is poised to gain traction going forward, driven by the ageing populations and the related increasing incidence rates of degenerative spinal disorders as well as 3D imaging technology. Spinal fusion surgery is set to become one of the most often performed surgeries from pole to pole.

Gilead takes the lead in the marketplace, whilst AbbVie acquires prominence by growing its market share in the USA. Pharmacos have begun concentrating on the introduction of new drugs since several drugs are currently in the pipeline.

The report provides an all-encompassing, unbiased analysis of the present-day state of the spinal fusion market and its possible future evolution during the next 5 years. It presents an all-round analysis and granular forecast of the worldwide spinal fusion market and procedures volume. It provides an analysis of the market share & forecast, as well as procedures volume share and forecast. The report focuses on the analysis of the market across the 8 leading countries, which are analysed from such viewpoints as: spinal fusion market and forecast and spinal fusion procedures volume. An analysis of key market drivers and challenges is included.